Pinnacle Wealth Planning Services’s Milestone Pharmaceuticals MIST Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$68.5K	Buy	+79,070	New	+$87.8K	0.01%	1085

Other funds holding MIST

Pavaki Capital Management Pueblo, Colorado $294M AUM 34.46% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return

RVW Wealth Los Angeles, California $1.56B AUM 16.49% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.14% 1-Year Est. Return

October Effect Virginia Beach, Virginia $98.3M AUM 66.25% 1-Year Est. Return

Secure Asset Management Troy, Michigan $753M AUM 20.9% 1-Year Est. Return

Atlantic Edge Private Wealth Management Jacksonville, Florida $487M AUM 24.51% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Pinnacle Wealth Planning Services's MIST Position: Q3 2026 in Review

Pinnacle Wealth Planning Services opened a new position in Milestone Pharmaceuticals (MIST) in Q3 2026: 79,070 shares worth $68.5K. The stake represents 0.01% of the portfolio and ranks #1085 among its holdings.

9 funds tracked by Wall St. Rank hold MIST as of Q3 2026.

Pinnacle Wealth Planning Services held 79,070 shares of Milestone Pharmaceuticals worth $68.5K as of Q3 2026.
Milestone Pharmaceuticals was a new Pinnacle Wealth Planning Services position in Q3 2026.
Milestone Pharmaceuticals made up 0.01% of Pinnacle Wealth Planning Services's portfolio in Q3 2026, its #1085 holding.
9 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q3 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q3 2026, filed 27 Oct 2026.